Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Severn Trent (SVT) by Bank of America
- Buy Smith & Nephew (SN.) by Edward Sheldon in The Motley Fool
- Buy Diageo (DGE) by Edward Sheldon in The Motley Fool
- Buy Ocado Group (OCDO) by Edward Sheldon in The Motley Fool
- Buy National Grid (NG.) by James Beard in The Motley Fool
- Buy Legal & General Group (LGEN) by Dr. James Fox in The Motley Fool
- Buy Hargreaves Lansdown (HL.) by Dr. James Fox in The Motley Fool
- Watch Abrdn (ABDN) by Jon Smith in The Motley Fool
- Watch Close Brothers Group (CBG) by Jon Smith in The Motley Fool
- Watch British Land Company (BLND) by Jon Smith in The Motley Fool
- Watch Primary Health Properties (PHP) by Jon Smith in The Motley Fool
- Buy Jet2 (JET2) by Phil Oakley in The Telegraph - Questor
- Hold M&G (MNG) by Deutsche Bank
- Buy PZ Cussons (PZC) by Deutsche Bank
- Outperform Kingfisher (KGF) by RBC Capital
- Outperform Watches of Switzerland Group (WOSG) by RBC Capital
- Overweight Reckitt Benckiser Group (RKT) by Barclays
- Equal Weight Relx plc (REL) by Barclays
- Hold BT Group (BT.A) by Berenberg
- Overweight Future (FUTR) by Barclays
GSK (GSK) Share Price
Health Care Sector
Members only
To view this content and much more please Sign Up
NOTE: This is based on 1,243 open tips for GSK (GSK)
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Kevin Godbold | – | 2023-09-29 07:10:00 29/09/2023 | – |
| – | Alan Oscroft | – | 2023-09-27 19:00:00 27/09/2023 | – |
| – | John Fieldsend | – | 2023-09-27 13:10:00 27/09/2023 | – |
| – | Morgan Stanley | – | 2023-09-25 07:12:00 25/09/2023 | – |
| – | Harvey Jones | – | 2023-09-19 18:00:00 19/09/2023 | – |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Kevin Godbold | – | 2023-09-29 07:10:00 29/09/2023 | – |
| – | Alan Oscroft | – | 2023-09-27 19:00:00 27/09/2023 | – |
| – | John Fieldsend | – | 2023-09-27 13:10:00 27/09/2023 | – |
| – | Morgan Stanley | – | 2023-09-25 07:12:00 25/09/2023 | – |
| – | Harvey Jones | – | 2023-09-19 18:00:00 19/09/2023 | – |